PriceTracker GLP-1
Loading the index…

Try

Find the cheapest for me
Loading the index…

Try

GLP-1 TV

Foundayo vs Mounjaro: Which Actually Works Better?

6:44Apr 2026

Today’s cheapest tirzepatide$69/mo at Wellmedr, sale price.Compare all tirzepatide prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.

Our summary

The creator compares two Eli Lilly products: the weekly Mounjaro (tirzepatide) injection and a new once-daily pill. In the captions the pill is called Zepbound, also known as orforglipron. He says the pill is a small molecule, non-peptide GLP-1 receptor agonist. Because of that, he says, it can be taken at any time, with or without food, unlike the oral Wegovy pill, which he says must be taken fasting with a 30 minute wait.

Published by Phill Double L on YouTube

As published by the channel. Not medical advice, and not an endorsement.

What else the video covers

On results, he says the highest pill dose in Lilly's phase 3 trial, 36 mg, produced an average loss of 12.4% of body weight over 72 weeks, around 27 lb. He contrasts this with Mounjaro, which he says often reaches upwards of 20% in trials, and attributes that to its dual action on GLP-1 and GIP. He lists Mounjaro's drawbacks as a weekly shot, rotating injection sites and refrigeration when traveling. He also says he used to forget his own doses and set a phone reminder.

On cost, he says the pill is rolling out at cash prices of $149 to $349 a month depending on dose, versus often well over $1,000 for Mounjaro without insurance or savings cards. He says both drugs cause nausea, constipation, diarrhea and indigestion, and that some early data suggest higher discontinuation with the daily pill. He gives US approval as April 5th, 2026, shipping via Lilly Direct on April 6th, and submissions in over 40 countries with no international dates or prices yet. He closes by suggesting Mounjaro for maximum weight loss or type 2 diabetes, and the pill for people with needle phobia, frequent travelers and shift workers, and says to talk to a doctor.

Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.

Takeaways

The main points, in the order they come up. Tap a time to play from there.

  1. 1:00 He says the pill is a small molecule that can be taken any time with or without food, unlike the oral Wegovy pill's fasting routine.
  2. 1:30 He reports the 36 mg dose averaged 12.4% body weight loss, about 27 lb, over 72 weeks in the phase 3 trial.
  3. 2:00 He explains that Mounjaro targets both GLP-1 and GIP, which he credits for results often above 20%, but it needs a weekly injection and refrigeration.
  4. 3:00 He states the pill's cash price is $149 to $349 a month, compared with often over $1,000 for Mounjaro without insurance or savings cards.
  5. 3:31 He says both drugs share common gut side effects, and early data suggest the daily pill may have slightly higher discontinuation rates.
  6. 5:32 He suggests discussing Mounjaro with a doctor for maximum weight loss or type 2 diabetes, and the pill for needle phobia, travel or shift work.

Key moments

Tap one to play from there.

  1. 0:00 The Big News: Foundayo is Here
  2. 0:21 Background
  3. 0:57 Foundayo
  4. 1:48 Statistics
  5. 3:08 Cost & Side Effects
  6. 4:16 Availability
  7. 5:30 Which One Should You Choose?
  8. 6:11 A Win For Us

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Wegovy, Zepbound, Mounjaro and Foundayo

Questions this video answers

How much weight did people lose on the Lilly weight loss pill compared with Mounjaro?

The creator says adults on the highest pill dose, 36 mg, lost an average of 12.4% of body weight over 72 weeks, around 27 lb. He says Mounjaro often reaches upwards of 20% in clinical trials, which he links to its dual GLP-1 and GIP action.

How much does the new Lilly weight loss pill cost without insurance?

According to the video, cash prices range from $149 to $349 a month depending on the dose, through pharmacies and Lilly Direct. He contrasts this with Mounjaro, which he says often sits well over $1,000 in America without insurance or savings cards.

Do you have to take the Lilly weight loss pill on an empty stomach?

No, the creator says. He explains that it is a small molecule rather than a peptide, so it can be taken any time of day, with or without food or water. He contrasts this with oral Wegovy, which he says requires fasting and a 30 minute wait.

When will the Lilly weight loss pill be available outside the US?

The creator says Lilly has submitted it for approval in over 40 countries, but exact launch dates and international pricing are not yet known. He says each country's regulator, such as the MHRA or EMA, works to its own timeline, and Lilly plans to launch shortly after each approval.

Videos on the same question

The closest videos in the library by what is said in them, not by title.

Read next

Our guides closest to what this video covers, with prices checked weekly.

  • Zepbound vs Mounjaro: one molecule, two labels, and why the label sets your price

    Zepbound and Mounjaro are both tirzepatide, made by Lilly, injected weekly at the same six doses from 2.5 to 15 mg. Mounjaro is approved for type 2 diabetes and Lilly's own site says it is not a weight-loss drug; Zepbound is the same molecule approved for obesity and sleep apnoea. That label decides everything downstream: insurers cover Mounjaro for diabetes and refuse it for weight, Zepbound is the box a plan can cover for weight, and Zepbound's cash price runs $299 to $699 by dose, while LillyDirect sells Mounjaro from $499 a month at every strength, against a list price of $1,112.16 per fill.

  • Mounjaro for weight loss, and why Zepbound exists

    Mounjaro is tirzepatide approved for type 2 diabetes. Zepbound is the same molecule from the same maker, approved for weight management, and it goes to the same 15 mg. So unlike Ozempic and Wegovy, there is no dose ceiling pushing you from one to the other: the reason people move is coverage and cash price, not strength. Using Mounjaro for weight is off-label and a prescriber's decision. In the one head-to-head trial, tirzepatide beat semaglutide, 20.2% mean body-weight loss at 72 weeks against 13.7%.

  • The best GLP-1 for weight loss, ranked by the evidence and then by the bill

    By weight lost, the order is settled: tirzepatide (Zepbound) first at 20.2% in the only head-to-head, then semaglutide 7.2 mg (Wegovy HD) at 18.7%, then semaglutide 2.4 mg (Wegovy) at 13.7% to 15.6%, then the pills. By what you pay, the order nearly inverts: compounded semaglutide from $39 a month, the Wegovy tablet from $149, Wegovy pen $349, Zepbound $299 to $699 by dose. The best one is where those two lists meet for your budget and your plan.

Next steps

Mounjaro prices

Insurance

Find more like it

Side effectsDose changeInjection techniqueCost and insuranceStopping and maintenanceThe trials

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV